Delcath's Chemotherapy Agent Gets Orp... - Reuters

Delcath's chemotherapy agent gets orphan drug statusReutersAug 31 (Reuters) - Delcath Systems Inc (DCTH.O) said US health regulators granted an orphan drug status to doxorubicin, a chemotherapy agent, for the treatment of primary liver cancer, sending its shares up 48 percent. The company said it tested ...FDA Grants Delcath Orphan-Drug Status For DoxorubicinNASDAQMarket Report -- In Play (DCTH)MSN MoneyDelcath Systems treatment gets special FDA statusThe Business InsiderReuters India -PR Newswire (press release)all 21 news articles »

BING NEWS:
  • Adding chemotherapy to hormone therapy helps control locally advanced prostate cancer, finds study
    For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to hormonal ...
    04/17/2024 - 6:17 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News